138 related articles for article (PubMed ID: 10688980)
1. Tolerance to morphine at the mu-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine.
Wang Z; Sadée W
Eur J Pharmacol; 2000 Feb; 389(2-3):165-71. PubMed ID: 10688980
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
[TBL] [Abstract][Full Text] [Related]
3. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
[TBL] [Abstract][Full Text] [Related]
4. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
5. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
6. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway.
Ai W; Gong J; Yu L
FEBS Lett; 1999 Jul; 456(1):196-200. PubMed ID: 10452557
[TBL] [Abstract][Full Text] [Related]
7. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
8. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
9. Interaction among mu-opioid receptors and alpha 2-adrenoceptors on SH-SY5Y human neuroblastoma cells.
Lameh J; Eiger S; Sadée W
Eur J Pharmacol; 1992 Sep; 227(1):19-24. PubMed ID: 1358661
[TBL] [Abstract][Full Text] [Related]
10. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
11. Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway.
Wallington CL; Peters DM; Gelb CR; Peterfreund RA
Brain Res; 2002 Jul; 944(1-2):73-81. PubMed ID: 12106667
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents.
Smart D; Lambert DG
Br J Pharmacol; 1995 Nov; 116(6):2655-60. PubMed ID: 8590985
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy mu-opioids.
Ammer H; Schulz R
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):263-71. PubMed ID: 8216227
[TBL] [Abstract][Full Text] [Related]
14. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
16. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.
Vetter I; Wyse BD; Monteith GR; Roberts-Thomson SJ; Cabot PJ
Mol Pain; 2006 Jul; 2():22. PubMed ID: 16842630
[TBL] [Abstract][Full Text] [Related]
17. Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats.
Wang D; Zeng J; Li Q; Huang J; Couture R; Hong Y
Br J Pharmacol; 2016 Apr; 173(7):1196-207. PubMed ID: 26750148
[TBL] [Abstract][Full Text] [Related]
18. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cAMP-dependent protein kinase in mu-opioid modulation of NMDA-mediated synaptic currents.
Xie CW; Lewis DV
J Neurophysiol; 1997 Aug; 78(2):759-66. PubMed ID: 9307110
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Ca2+/calmodulin translocation activated by mu-opioid (OP3) receptor.
Wang D; Tolbert LM; Carlson KW; Sadée W
J Neurochem; 2000 Apr; 74(4):1418-25. PubMed ID: 10737597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
